Search for: "NYU Law Review"
Results 201 - 220
of 1,474
Sort by Relevance
|
Sort by Date
13 Apr 2022, 3:19 pm
Aaron Sibarium reports in the Washington Free Beacon: Over the next 24 hours, 11 student groups wrote to the law school's all-student listserv to express their support for the statement: the Black Allied Law Students Association, the Middle Eastern Law Students Association, the Muslim Law Students Association, the South Asian Law Students Association, the Disability Allied Law Students Association, the National Lawyers Guild, the Women of… [read post]
12 Apr 2022, 11:01 am
He is a Non-Resident Senior Fellow at the NYU Law School Reiss Center on Law and Security. [read post]
31 Mar 2022, 9:05 pm
Sprigman of the NYU School of Law responded to concerns about environmental destruction and labor exploitation in the fast fashion industry. [read post]
24 Mar 2022, 11:20 am
The article is part of an NYU Journal of Law and Liberty Symposium on "Responding to Emergency: A Blueprint for Liberty in A Time of Crisis" (co-sponsored by the Pacific Legal Foundation). [read post]
18 Mar 2022, 9:06 pm
Sprigman of the NYU School of Law respond to concerns about environmental destruction and labor exploitation in the fast fashion industry. [read post]
17 Mar 2022, 9:03 pm
The post Week in Review first appeared on The Regulatory Review. [read post]
14 Mar 2022, 9:58 am
For example, the NYU Law Review requires anonymous submissions, but Scholastica has not yet added a designation indicating this. [read post]
2 Mar 2022, 8:11 am
” “‘The optics are certainly better if a company hires a firm with which it has no prior professional relationship,’ says NYU law professor Stephen Gillers. [read post]
23 Feb 2022, 2:30 pm
But I expect NYU law students and faculty will be allowed to attend. [read post]
18 Feb 2022, 3:15 am
In recent months, long-time SPAC structures that were spelled out in hundreds of registration statements reviewed by the Staff of Corp Fin have been called into question, most notably in a lawsuit filed by former SEC commissioner & NYU Law School professor Robert Jackson & Yale Law School professor John Morley. [read post]
17 Feb 2022, 9:03 pm
In an article in the Yale Journal on Regulation, Michael Klausner, professor at Stanford Law School, Michael Ohlrogge, professor at the NYU School of Law, and Emily Ruan, former research associate at Stanford Law School, discussed Special Purpose Acquisition Companies—commonly referred to as SPACs. [read post]
16 Feb 2022, 9:30 pm
Maggie Blackhawk (Fond du Lac Band of Lake Superior Ojibwe) is a professor of law at NYU School of Law. [read post]
16 Feb 2022, 12:22 am
“Judgments Convention: Application to Governments”, Netherlands International Law Review (NILR) 67 (2020), pp 121-137 Beaumont, Paul; Holliday, Jane (eds.) [read post]
10 Feb 2022, 10:18 pm
Lederman was a Note & Comment editor on the NYU Law Review. [read post]
5 Feb 2022, 5:00 am
Lederman was a Note & Comment editor on the NYU Law Review. [read post]
4 Feb 2022, 5:53 am
Massengill, Mayer Brown LLP, on Sunday, January 30, 2022 Tags: Boards of Directors, Conflicts of interest, Delaware cases, Delaware law, Fairness review, Fiduciary duties, Merger litigation, Mergers & acquisitions, Securities litigation, SPACs, Special purpose vehicles Theranos: The Limits of the “Fake It Till You Make It” Strategy Posted by Carrie H. [read post]
31 Jan 2022, 1:32 pm
In their conspicuous November 2020 paper, “A Sober Look at SPACs” (here), Stanford Law Professor Michael Klausner, NYU Law Professor Michael Ohlrogge, and Stanford Research Associate Emily Ruan warned, among other things, that SPAC shares were highly diluted, that their post-SPAC-merger performance was poor, and that sponsors’ returns were extraordinarily high. [read post]
28 Jan 2022, 5:47 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, January 28, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of January 21–27, 2022. [read post]
21 Jan 2022, 8:35 am
Céline Gounder at NYU’s Grossman School of Medicine bluntly noted that “neither Merck nor Pfizer is incentivized to run a combination therapy trial. [read post]
12 Jan 2022, 7:29 am
But it is one of a few such incidents that have come up recently, with others involving the American Indian Law Review, the Washington University Law Review, and--with a slightly different set of facts--the NYU Review of Law & Social Change. [read post]
